General Neurology
British anti-Lewisite
Nov. 03, 2025
MedLink, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
01.22.2026
Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board.
The Romberg sign is one of the most enduring artifacts of the 19th-century neurologic examination, indicating postural instability with eyes closed in a patient who remains stable with eyes open. Initially described in the context of tabes dorsalis, its clinical utility has since expanded to encompass nearly all causes of proprioceptive deficits, from peripheral neuropathies to cervical myelopathies. However, as we move further into the 21st century, the test is the subject of significant debate regarding its specificity, safety, and continued relevance in an era of high-precision diagnostics.
Although synonymous with the German neurologist Moritz Heinrich Romberg, the sign's history is a tapestry of 19th-century observations. In 1836, the English physician Marshall Hall described a patient who could walk safely while fixating on the ground but stumbled in the dark, noting the patient’s inability to "poise" himself without visual cues. Simultaneously, Bernardus Brach observed that patients with tabes dorsalis were "dependent upon their cane for support" and found walking in the dark nearly impossible.
Romberg’s pivotal contribution in 1840 was to formalize this symptom as a bedside clinical sign. He described the characteristic "oscillations" and subsequent falls that occurred when patients were told to shut their eyes, famously stating that, for these patients, "their eyes are their regulators." It was not until the late 19th century that British neurologist William Gowers definitively linked this phenomenon to dorsal column lesions, thereby transforming the sign from a pathognomonic marker of neurosyphilis into a general indicator of sensory ataxia.
To interpret the Romberg sign, a clinician must understand that central postural control depends on integrating three peripheral modalities: vision, the vestibular apparatus, and proprioception. Under normal conditions, the functional ranges of these systems overlap, providing redundancy. A healthy individual can maintain stability even if one system is eliminated (eg, by closing the eyes) because the remaining two systems—vestibular and proprioceptive—provide sufficient compensation.
A positive Romberg sign occurs when proprioceptive input is compromised. In these cases, the patient relies heavily on visual feedback (exteroception) to maintain balance with eyes open. When this visual "regulator" is removed by closing the eyes, the remaining vestibular system is insufficient to prevent postural sway or falls.
Proprioception is an "ensemble" of sensory inputs. The muscle spindle is considered the primary receptor, detecting changes in muscle length and velocity. This is supplemented by cutaneous receptors (skin strain) and joint receptors (limit detectors at extreme angles), as well as efferent "outflow" signals from motor commands. Degradation of this complex neurophysiological process can manifest as a positive Romberg sign.
Despite its ubiquity, there is no standardized approach to administering the Romberg test. Variability exists in:
The sharpened Romberg test
To increase sensitivity, clinicians often use the sharpened Romberg test, which requires the patient to stand in a heel-to-toe tandem position. This narrows the base of support, making it more challenging to maintain equilibrium and potentially revealing subtle proprioceptive or vestibular deficits that a standard test might miss.
The walking Romberg sign
Perhaps the most significant modern adaptation is the walking Romberg sign. In this dynamic version, the patient walks 5 meters with eyes open, then repeats the task with eyes closed. A positive Romberg sign is defined as swaying, falling, or an inability to complete the walk due to instability.
Research indicates that this version is significantly more sensitive than the traditional standing test for detecting cervical myelopathy. In a study of 50 patients, the traditional Romberg test was positive in only 34% of cases, whereas the walking Romberg test was positive in 74.5%. Every patient with a positive traditional test also tested positive on the walking version, but 21 patients were identified only by the walking adaptation.
The Romberg sign remains a critical tool for distinguishing between sensory ataxia and cerebellar ataxia.
Controversy note. Although classic teaching held that the Romberg sign is absent in cerebellar disease, modern posturography shows that patients with vestibulo-cerebellar or spino-cerebellar lesions (specifically in the anterior vermis) exhibit increased sway with eyes closed. Thus, while sensory ataxia yields a more "classic" Romberg, cerebellar ataxia does not strictly rule out a positive result.
For clinicians screening for cervical spondylotic myelopathy, the combination of the Hoffman sign and the Walking Romberg sign is highly effective. Although the Hoffman sign alone has a sensitivity of only 58% for cord compression, the combination of these two tests—assessing upper- and lower-limb neurologic function—achieves 96% sensitivity for ruling out clinically significant myelopathy. This combination is particularly useful in complex differential diagnoses involving fibromyalgia, carpal tunnel syndrome, or chronic neck pain.
A modern controversy has emerged regarding whether the Romberg sign should be omitted from routine practice.
The case against: redundancy and risk. Critics, including Martin Turner, argue that the Romberg test "no longer stands up." The primary concerns are:
The case for: functional insight. Conversely, proponents, including Andrew Lees, argue that the Romberg sign remains essential. Its key strengths include:
Recent advances in neurology have introduced wireless sensing technology (microwave sensing) to quantify the Romberg sign and gait. By using omnidirectional antennas to detect fluctuations in wireless signals caused by body movement, researchers have achieved accuracy exceeding 96% in distinguishing between sensory ataxia and cerebellar ataxia. This technology addresses "self-consciousness" issues, where patients might inadvertently alter their sway when they know they are being watched.
The Romberg sign is not a single, static test but a clinical window into the patient's sensory-motor integration. Although its traditional form may be criticized for limited precision, its dynamic adaptations, such as the walking Romberg test, offer high sensitivity for detecting critical conditions, including cervical myelopathy. The Romberg sign should not be viewed as a redundant relic but as a nuanced component of a comprehensive semiologic evaluation. When combined with adjuncts such as the Hoffman reflex and tandem walking, it provides indispensable diagnostic clarity.
Findlay GF, Balain B, Trivedi JM, Jaffray DC. Does walking change the Romberg sign? Eur Spine J 2009;18(10):1528-31. PMID 19387702
Lanska DJ, Goetz CG. Romberg's sign: development, adoption, and adaptation in the 19th century. Neurology 2000;55(8):1201-6. PMID 11071500
Lees A. Replies to “Romberg's sign no longer stands up”: Reply to “Romberg's test no longer stands up”. Pract Neurol 2016;16(5):421. PMID 27630258
Nonnekes J, Goselink RJM, Růžička E, Fasano A, Nutt JG, Bloem BR. Neurological disorders of gait, balance and posture: a sign-based approach. Nat Rev Neurol 2018;14(3):183-9. PMID 29377011
Turner MR. Romberg's test no longer stands up. Pract Neurol 2016;16(4):316. PMID 26951768
Zhang Q, Zhou X, Li Y, Yang X, Abbasi QH. Clinical recognition of sensory ataxia and cerebellar ataxia. Front Hum Neurosci 2021;15:639871. PMID 33867960
Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.
MedLink, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125